Sign in

YI on Nasdaq

111, Inc.

111, Inc. is a retail-Drug Stores and Proprietary Stores company, active since 2013.2 It is headquartered in George Town, Cayman Islands.2 Its shares trade on Nasdaq under the symbol YI.2

Price unavailable

Last updated Oct 21, 2026.

Overview

$1.8BRevenue, fiscal 20253
-$3.2MNet income, fiscal 20253

Compare with Guardian Pharmacy Services, Inc., PetMed Express or Rite Aid, or pick any stock.

  • TickerYI on Nasdaq2
  • IndustryRetail-Drug Stores and Proprietary Stores2
  • HeadquartersGeorge Town, Cayman Islands2
  • Incorporated inCayman Islands4
  • Business address3-4/F, No.295 Zuchongzhi Road, Pudong New Area, Shanghai, 2012034
  • Filer categoryNon-accelerated filer4
  • Legal formcompany limited by shares2
  • LEI549300IRZ6WV1NLO5Z752
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressPO Box 31119, KY1-1205 George Town, Cayman Islands2
  • Registered withGeneral Registry, OI-2780412

See how the biggest companies compare on our leaderboards

In 2010, our founders launched 1 Drugstore, one of the first online retail pharmacies in China. In January 2013, Yihao Pharmaceutical Chain established its subsidiary Shanghai Yaowang E-Commerce Co., Ltd., or Shanghai Yaowang. In May 2013, Yao Wang Holdings Ltd. was incorporated under the laws of the Cayman Islands as our offshore holding company, which changed its name to New Peak Group in June 2015, and subsequently changed its name to 111, Inc. in April 2018. In June 2013, Yao Wang Corporation Limited, or Yao Wang, was incorporated in Hong Kong as a wholly owned subsidiary of 111, Inc. 1 Pharmacy Technology (Shanghai) Co., Ltd. (previously known as Yao Fang Information Technology (Shanghai) Co., Ltd. and 1 Pharmacy Yao Fang Technology (Shanghai) Co., Ltd.), or 1 Pharmacy Technology, was established in August 2013 as a wholly owned subsidiary of Yao Wang in the PRC. In September 2013, …5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

40.3%Gross margin3
-0.0%Operating margin3
-0.2%Net margin3
-9.0%Revenue growth, 20253
$16.4MFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Drugs brought in 91% of the revenue 111, Inc. broke down this way in fiscal 2025.

  1. Drugs11.6B CNY391%down 13% from 2024
  2. Nutritional Supplements434.7M CNY33%down 21% from 2024
  3. Other Products233.7M CNY32%up 16% from 2024
  4. Business To Consumer B2c Business223.2M CNY32%down 15% from 2024
  5. Medical Supplies And Devices152.4M CNY31%up 6% from 2024
  6. MP Service56.7M CNY30%down 13% from 2024
Products and services by year
Products and services202320242025
Drugs13.9B CNY13.4B CNY11.6B CNY
Nutritional Supplements631.1M CNY550.5M CNY434.7M CNY
Other Products170.2M CNY201.8M CNY233.7M CNY
Business To Consumer B2c Business358.0M CNY261.2M CNY223.2M CNY
Medical Supplies And Devices157.5M CNY144.3M CNY152.4M CNY
MP Service70.3M CNY65.5M CNY56.7M CNY

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue94¢$1.7B
  • Other costs6¢$103.4M
  • Income tax0¢$2.0K

Out of $1.8B in revenue.3 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending4¢$636.0K
  • Kept or used elsewhere96¢$16.4M

Out of $17.0M of cash from operations.3

Financial statements

Revenue67891011123$1.8B in 2025+591% since 2018
0$1.0B$2.0B$3.0B2018: $259.8M$259.8M20182019: $567.7M$567.7M2019+119%2020: $1.3B$1.3B2020+121%2021: $1.9B$1.9B2021+55%2022: $2.0B$2.0B2022+1%2023: $2.1B$2.1B2023+7%2024: $2.0B$2.0B2024−6%2025: $1.8B$1.8B2025−9%
Gross profit891011123$723.4M in 2025+594% since 2018
0$250.0M$500.0M$750.0M$1.0B2018: $104.3M$104.3M20182019: $165.2M$165.2M2019+58%2020: $365.8M$365.8M2020+121%2021: $621.1M$621.1M2021+70%2022: $840.0M$840.0M2022+35%2023: $849.0M$849.0M2023+1%2024: $829.2M$829.2M2024−2%2025: $723.4M$723.4M2025−13%
Operating income67891011123-$340.0K in 2025−99% since 2018
-$150.0M-$100.0M-$50.0M0$50.0M2018: -$58.2M-$58.2M20182019: -$70.9M-$70.9M2019+22%2020: -$72.5M-$72.5M2020+2%2021: -$100.8M-$100.8M2021+39%2022: -$53.8M-$53.8M2022−47%2023: -$49.3M-$49.3M2023−8%2024: $289.0K$289.0K20242025: -$340.0K-$340.0K2025
Net income67891011123-$3.2M in 2025−99% since 2018
-$400.0M-$300.0M-$200.0M-$100.0M02018: -$382.0M-$382.0M20182019: -$72.1M-$72.1M2019−81%2020: -$71.6M-$71.6M2020−1%2021: -$97.5M-$97.5M2021+36%2022: -$54.5M-$54.5M2022−44%2023: -$49.8M-$49.8M2023−9%2024: -$2.8M-$2.8M2024−94%2025: -$3.2M-$3.2M2025+13%

Every line of the income statement as filed: the last 3 fiscal years, latest first.3

Period ending2025-12-312024-12-312023-12-31
Net revenues12.6B CNY14.4B CNY14.9B CNY
Cost of products sold-11.8B CNY-13.6B CNY-14.1B CNY
Fulfillment expenses-345.2M CNY-381.0M CNY-400.5M CNY
Selling and marketing expenses-258.6M CNY-313.9M CNY-448.4M CNY
General and administrative expenses-69.5M CNY-70.9M CNY-224.2M CNY
Technology expenses-60.4M CNY-69.6M CNY-124.3M CNY
Other operating (expenses) income, net7.9M CNY8.4M CNY-1.6M CNY
Total operating costs and expenses-12.6B CNY-14.4B CNY-15.3B CNY
(Loss) Income from operations-2.4M CNY2.1M CNY-350.1M CNY
Interest income3.9M CNY7.0M CNY8.8M CNY
Interest expense-35.6M CNY-28.3M CNY-20.1M CNY
Foreign exchange gain (loss)480.0K CNY-909.0K CNY610.0K CNY
Other income (loss), net11.1M CNY-595.0K CNY7.6M CNY
Loss before income taxes-22.5M CNY-20.7M CNY-353.2M CNY
Income tax expense-13.0K CNY-96.0K CNY-251.0K CNY
Net loss-22.5M CNY-20.8M CNY-353.4M CNY
Net loss attributable to non-controlling interest4.1M CNY8.4M CNY16.8M CNY
Net loss attributable to redeemable non-controlling interest1.1M CNY2.0M CNY30.9M CNY
Adjustment attributable to redeemable non-controlling interest-49.1M CNY-54.4M CNY-86.9M CNY
Net loss attributable to ordinary shareholders-66.4M CNY-64.7M CNY-392.7M CNY
Unrealized gains of available-for-sale securities677.0K CNY1.1M CNY4.3M CNY
Realized gains of available-for-sale securities-646.0K CNY-1.2M CNY-4.2M CNY
Foreign currency translation adjustments-1.8M CNY2.0M CNY-3.2M CNY
Comprehensive loss-68.1M CNY-62.9M CNY-395.8M CNY
Loss per share, basic-0.38 CNY-0.38 CNY-2.33 CNY
Loss per share, diluted-0.38 CNY-0.38 CNY-2.33 CNY
Weighted average number of shares used in computation of loss per share, basic174.0M shares171.8M shares168.6M shares
Weighted average number of shares used in computation of loss per share, diluted174.0M shares171.8M shares168.6M shares
Other comprehensive income (loss), net of tax0 CNY0 CNY0 CNY

Compare 111, Inc. with another company

Corporate structure

111, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of 111, Inc.

  • Yu Gang Filed SCHEDULE 13D on 111, Inc., latest Sep 17, 2026 (5 filings since Sep 9, 2022)
  • ClearVue Partners, L.P. Filed SC 13G/A on 111, Inc., latest Feb 10, 2022
  • 111, Inc. George Town, Cayman Islands

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What 111, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Accumulated depreciation80.2M CNY3 Dec 31, 202579.2M CNY3 Dec 31, 2024+1.2%
Property and equipment, net$3.0M3 Dec 31, 2025$4.5M12 Dec 31, 2024−33.1%
Operating-lease assets (leased space)$6.3M3 Dec 31, 2025$12.2M12 Dec 31, 2024−48.3%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$73.1M3 Dec 31, 2025$63.3M12 Dec 31, 2024+15.4%
Marketable securities, current$7.2M3 Dec 31, 2025$7.1M11 Dec 31, 2023+1.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$124.0K3 Dec 31, 2025$197.0K12 Dec 31, 2024−37.1%
Accumulated amortization14.9M CNY3 Dec 31, 202510.5M CNY3 Dec 31, 2024+42.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$142.8M3 Dec 31, 2025$190.1M12 Dec 31, 2024−24.9%

Leadership

Who has led 111, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (2)

Timeline

  1. Apr 25, 2013Founded 111, Inc. is founded2

Filings

79 filings to the SEC since October 2021: 6 annual reports, 19 insider forms, 6 large holders, 48 other. The latest 20:

  1. Sep 29, 20264 OWNERSHIP DOCUMENT EDGAR
  2. Sep 28, 20266-K EDGAR
  3. Sep 24, 20264 OWNERSHIP DOCUMENT EDGAR
  4. Sep 17, 2026SCHEDULE 13D EDGAR
  5. Sep 17, 20266-K EDGAR
  6. Sep 17, 20266-K EDGAR
  7. Jun 16, 20264 OWNERSHIP DOCUMENT EDGAR
  8. Jun 16, 20264 OWNERSHIP DOCUMENT EDGAR
  9. Jun 12, 20264 OWNERSHIP DOCUMENT EDGAR
  10. Jun 11, 20264 OWNERSHIP DOCUMENT EDGAR
  11. Jun 9, 2026144 EDGAR
  12. Jun 4, 20266-K EDGAR
  13. May 29, 20264 EDGAR
  14. May 29, 20264 EDGAR
  15. May 29, 20264 EDGAR
  16. May 13, 20264 EDGAR
  17. May 13, 20264 EDGAR
  18. May 13, 20264 EDGAR
  19. May 13, 20264 EDGAR
  20. Apr 30, 202620-F EDGAR

The 79 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

36 open-market trades by officers, directors and large owners since October 2021: 0 buys and 36 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 28, 2026Chen Yang LukeDirectorSale38,120$0.18$6.9KForm 4
Sep 23, 2026Chen Yang LukeDirectorSale44,000$0.18$7.9KForm 4
Sep 23, 2026Chen Yang LukeDirectorSale44,000$0.18$7.9KForm 4
Jun 15, 2026Chen Yang LukeDirectorSale44,000$0.23$10.1KForm 4
Jun 15, 2026Chen Yang LukeDirectorSale44,000$0.23$10.1KForm 4
Jun 15, 2026Chen Yang LukeDirectorSale44,000$0.23$10.1KForm 4
Jun 15, 2026Sun Jian DavidDirectorSale58,800$0.23$13.5KForm 4
Jun 12, 2026Chen Yang LukeDirectorSale49,920$0.23$11.5KForm 4
Jun 12, 2026Chen Yang LukeDirectorSale49,920$0.23$11.5KForm 4
Jun 12, 2026Chen Yang LukeDirectorSale49,920$0.23$11.5KForm 4
Jun 11, 2026Sun Jian DavidDirectorSale111,100$0.23$25.6KForm 4
Jun 11, 2026Sun Jian DavidDirectorSale111,100$0.23$25.6KForm 4
Jun 10, 2026Sun Jian DavidDirectorSale115,440$0.22$25.4KForm 4
Jun 10, 2026Sun Jian DavidDirectorSale115,440$0.22$25.4KForm 4
Jun 10, 2026Sun Jian DavidDirectorSale115,440$0.22$25.4KForm 4
Jun 9, 2026Sun Jian DavidDirectorSale12,000$0.23$2.8KForm 4
Jun 9, 2026Sun Jian DavidDirectorSale12,000$0.23$2.8KForm 4
Jun 9, 2026Sun Jian DavidDirectorSale12,000$0.23$2.8KForm 4
May 27, 2026Chen Yang LukeDirectorSale3,400$0.25$850Form 4
May 27, 2026Chen Yang LukeDirectorSale3,400$0.25$850Form 4

All 36 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Serenus Wealth Advisors, LLC4,320$358.7K0.1%No change
Citadel Advisors LLC17,339$75.3K0.0%New
Renaissance Technologies LLC12,914$56.0K0.0%−100
UBS Group AG1,597$6.9K0.0%+1,497
SBI Securities Co., Ltd.149$6470.0%+5
Morgan Stanley113$4900.0%No change
Jpmorgan Chase & Co47$1940.0%−5
Rhumbline Advisers22$950.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How 111, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAR111, Inc.1
  • CIK0001738906
  • Filer statusNon-accelerated filer not an emerging growth company; not a shell company5
  • Incorporated inCayman Islands5
  • Fiscal year endsDecember 311
  • Industry code (SIC)5912 Retail-Drug Stores and Proprietary Stores1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address3-4/F, No.295 Zuchongzhi Road, Pudong New Area, Shanghai, 201203, China1
  • Phone8621205366661
  • Shares outstanding175,702,298 Common Stock shares; 103,702,298 Common Class A, Common Stock shares; 72,000,000 Common Class B, Common Stock shares as of Dec 31, 20255
  • AuditorGrant Thornton Zhitong Certified Public Accountants LLP, Shanghai, the People’s Republic of China PCAOB ID 1487; no auditor attestation of internal control over financial reporting5
  • On EDGAR sinceMay 17, 20181
  • Filings132 in all: 6-K (49), 4 (13), CORRESP (12), UPLOAD (11), 20-F (8), 3 (6), SC 13G (5), SC 13G/A (5)1
    All 25 form types

    DRSLTR (3), SC 13D/A (3), DRS/A (2), F-1/A (2), 144 (1), 20-F/A (1), 424B4 (1), 8-A12B (1), CERT (1), DRS (1), EFFECT (1), F-1 (1), FWP (1), NT 20-F (1), S-8 (1), SC 13D (1), SCHEDULE 13D (1)

  • Latest filingsAnnual report (20-F) Apr 30, 2026

Securities registered for trading

ClassSymbolExchange
American depositary shares (one American depositary share representing twenty Class A ordinary shares, par value US$0.00005 per share)YINasdaq
Class A ordinary shares, par value US$0.00005 per share*YINasdaq

From the cover page of the 20-F filed Apr 30, 2026 (Section 12(b) of the Exchange Act).5

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16